The target of rapamycin (TOR) signaling pathway is involved in starch accumulation in various eukaryotic organisms; however, the molecular mechanism behind this phenomenon in eukaryotes has not been elucidated. We report a regulatory mechanism of starch accumulation by TOR in the unicellular red alga, Cyanidioschyzon merolae. The starch content in C. merolae after TOR-inactivation by rapamycin, a TOR-specific inhibitor, was increased by approximately 10-fold in comparison with its drug vehicle, dimethyl sulfoxide. However, our previous transcriptome analysis showed that the expression level of genes related to carbohydrate metabolism was unaffected by rapamycin, indicating that starch accumulation is regulated at posttranscriptional levels. In this study, we performed a phosphoproteome analysis using liquid chromatography-tandem mass spectrometry to investigate potential post-transcriptional modifications, and identified 52 proteins as candidate TOR substrates. Among the possible substrates, we focused on the function of CmGLG1, because its phosphorylation at the Ser613 residue was decreased after rapamycin treatment, and overexpression of CmGLG1 resulted in a 4.7-fold higher starch content. CmGLG1 is similar to the priming protein, glycogenin, which is required for the initiation of starch/glycogen synthesis, and a budding yeast complementation assay demonstrated that CmGLG1 can functionally substitute for glycogenin. We found an approximately 60% reduction in the starch content in a phospho-mimicking CmGLG1 overexpression strain, in which Ser613 was substituted with aspartic acid, in comparison with the wild-type CmGLG1 overexpression cells. Our results indicate that TOR modulates starch accumulation by changing the phosphorylation status of the CmGLG1 Ser613 residue in C. merolae.
INTRODUCTION
Target of rapamycin (TOR) is a conserved serine/threonine protein kinase in eukaryotes, and plays a central role in various cellular processes, including cell growth, metabolism and translation (Laplante and Sabatini, 2012) . In yeast and mammals, TOR is found in two structurally and functionally distinct multi-protein complexes, known as TOR complex 1 (TORC1) and TOR complex 2 (TORC2). TORC1 is involved in cell growth and metabolism in response to the nutrient status and energy availability, and its activity is specifically inhibited by the TOR-specific inhibitor, rapamycin (Heitman et al., 1991) . In contrast, TORC2 is involved in cell skeleton regulation, as well as other cellular processes related to growth, and is not specifically inhibited by rapamycin. To date, only TORC1 has been reported in plant lineages (Wullschleger et al., 2006; Maegawa et al., 2015; Saxton and Sabatini, 2017) .
Although rapamycin is a useful drug for investigating TOR functions in eukaryotes, most land plants and algae do not show clear phenotypes in response to rapamycin treatment (Caldana et al., 2013; Imamura et al., 2013) , making assessments of TOR function in these lineages difficult. To overcome this problem, some research groups have successfully constructed rapamycin-susceptible plant and algal strains through the expression of the yeast FKBP12 protein (Sormani et al., 2007; Imamura et al., 2013) . Instead of rapamycin, some recent studies have suggested using novel ATP-competitive inhibitors, such as AZD8055 and Torin1, which can also be used to reveal various cellular processes of TOR, like cell growth, photosynthesis and phytohormone signaling (Montan e and Menand, 2013; Dong et al., 2015; Song et al., 2017) . Other approaches include the use of artificial microRNAs for Arabidopsis thaliana TOR (Caldana et al., 2013) . Using these strains and inhibitors, several roles of TOR in various cellular processes have so far been revealed (Mahfouz et al., 2006; Sormani et al., 2007) . For example, TOR is involved in the accumulation of carbon storage molecules like triacylglycerols (TAGs) and starch (Imamura et al., 2015; Couso et al., 2016; Prioretti et al., 2017; J€ uppner et al., 2018) , indicating that TOR is a checkpoint kinase for TAG and starch accumulation in plant lineages.
Microalgae are considered as promising renewable energy bioresources because of their high photosynthetic activities and growth rates, their elevated lipid and carbohydrate contents in comparison with land plants, and the fact that they do not compete for resources used in agricultural food production (Chisti, 2007) . Moreover, TAGs and starch produced by microalgae are good feedstock for the production of biodiesel and bioethanol/useful chemicals, respectively (Daroch et al., 2013; Yamaguchi et al., 2017 ). An understanding of the regulatory processes that govern carbon reserve accumulation in microalgae is important for improving productivity, and TOR-signaling seems to be a promising pathway for modulating biofuel production capabilities in various microalgae. However, the fundamental mechanism by which TOR controls the synthesis of TAGs and starch in microalgae and plants remains largely unknown. In contrast, a previous study revealed that the transcription of the glycogen phosphorylase gene is downregulated in mammals when TOR is inactivated, ultimately leading to the accumulation of glycogen in cells (Bentzinger et al., 2008) . In yeast, the TOR-signaling pathway dephosphorylates TAP42 in response to TOR-inactivation, resulting in the phosphorylation of the transcription factor Msn2p. The phosphorylated Msn2p binds to the stress response element regulatory sequence in the promoter region of glycogen synthesis-related genes, which induces the accumulation of glycogen in cells (Franc ßois et al., 2012) . Thus, one strategy for elucidating the role of TOR in the synthesis of TAGs and starch is to identify TOR substrates that are related to the metabolism of these storage molecules. Although many TOR substrates have been identified by genetic and phosphoproteomic analyses in mammals and yeast (Hsu et al., 2011; Robitaille et al., 2013) , to date, only a few target substrates of TOR have been identified in plant lineages. These include PP2A, which is involved in nitrogen remobilization (Ahn et al., 2011);  kinase S6K, which is important for controlling translation (Xiong and Sheen, 2012; Dobrenel et al., 2016) ; transcription factor E2F, which helps activate the expression of Sphase genes (Xiong et al., 2013) ; and BiP, which is an endoplasmic reticulum chaperone (D ıaz-Troya et al., 2011) .
Cyanidioschyzon merolae is a unicellular red alga that is habituated to acid hot springs (pH 1-3, 40-50°C), and contains only a single chloroplast, mitochondrion and nucleus (Matsuzaki et al., 2004) . The complete genome sequences of these three organelles are available, and the simple and small nuclear genome (16.5 Mb) and low gene redundancy have previously been characterized (Matsuzaki et al., 2004; Nozaki et al., 2007) . Because of the elucidation of these biological characteristics, and because various genetic, molecular biology and biochemical tools have been well established (Imamura et al., 2008 (Imamura et al., , 2010 Ohnuma et al., 2008) , this alga is considered to be a good model organism for studying various molecular functions of photosynthetic eukaryotes. Furthermore, we recently succeeded in establishing a novel C. merolae host strain, SF12, that has rapamycin-sensitive and uracil-auxotrophic phenotypes . These features also make C. merolae cells suitable for the analysis of TOR function. Our previous microarray data for rapamycin-treated C. merolae indicated that the expression levels of 148 and 64 genes are upregulated and downregulated, respectively (Imamura et al., 2015) . However, we did not observe any changes in the transcript levels of genes related to carbohydrate metabolism, implying that carbohydrate metabolism is regulated at post-transcriptional levels. Therefore, in the present study, we performed a liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based proteomic analysis and identified 52 proteins as candidate TOR substrates. Among these, we characterized a glycogenin-like protein that is involved in starch accumulation in yeast and other organisms (Cheng et al., 1995; Chatterjee et al., 2005; De Paula et al., 2005) , and revealed that phosphorylation changes that are regulated by TOR-signaling are critical for starch accumulation in C. merolae.
RESULTS
Starch accumulation after target of rapamycin-inactivation by rapamycin in the Cyanidioschyzon merolae SF12 strain It has been recently documented in various microalgae that TOR-inactivation by rapamycin enhances the intracellular accumulation of TAGs (Caldana et al., 2013; Imamura et al., 2015 Imamura et al., , 2016 Couso et al., 2016; Prioretti et al., 2017) . In algal cells subjected to various stress conditions, lipid and carbohydrate syntheses are mutually linked because they generally increase simultaneously (Fan et al., 2012; Johnson and Alric, 2013) , raising the possibility that TOR also plays an important role in starch accumulation in microalgae. To examine this hypothesis, we first investigated the starch accumulation pattern under rapamycin treatment conditions in C. merolae SF12 cells. It should be noted that red algae, including C. merolae, accumulate floridean starch in the cytosolic area (Viola et al., 2001; Barbier et al., 2005) . The a-glucan synthesized by C. merolae mainly contains semi-amylopectin-type, but not amylose-type, glucan (Hirabaru et al., 2010) . In this study, we hereafter refer to floridean starch as starch. The cells accumulated significantly higher amounts of starch 12 h after exposure to rapamycin, in comparison with the dimethyl sulfoxide (DMSO) control. These levels increased further with time, and were approximately 10-fold higher than the control after 48 h (Figure 1a) . Our results clearly indicate that TOR-inactivation by rapamycin increased the starch content in C. merolae. As with the TOR-inactivation conditions, high starch levels are generally observed under nitrogen depletion conditions in many algae as the excessive reducing power of NADPH and ATP is used for synthesizing starch (Siaut et al., 2011; Fan et al., 2012) . Moreover, TOR is important for controlling cellular metabolic processes and growth in response to nitrogen availability in yeast and mammals (Beck and Hall, 1999; Cooper, 2002; Matsuo et al., 2007) . On the basis of the assumption that TOR-signaling is a major pathway for starch accumulation, one would expect that the starch contents under rapamycin treatment, nitrogen depletion, and nitrogen depletion combined with rapamycin treatment would be almost the same. Consistently, no significant differences were observed in the starch contents between all three conditions, which, at least under nitrogen depletion conditions, suggests that TOR is the major pathway that governs starch accumulation (Figure 1b) .
Target of rapamycin-dependent phosphorylated proteins in the Cyanidioschyzon merolae SF12 strain
To further clarify the molecular mechanism behind the starch accumulation under TOR-inactivation and nitrogen depletion conditions in C. merolae, we first checked available microarray data for C. merolae exposed to rapamycin treatment or nitrogen depletion conditions (Imamura et al., 2015) . No upregulated or downregulated genes related to carbohydrate metabolism were identified, suggesting that C. merolae regulates carbohydrate metabolism at posttranscriptional levels. It has previously been reported that TOR controls metabolism through the phosphorylation statuses of TOR-signaling substrates (Hsu et al., 2011; Robitaille et al., 2013) . Therefore, we next performed a phosphoproteome analysis to identify TOR-dependent phosphorylated proteins using an LC-MS/MS system. To evaluate the reliability of this analysis, phosphorylation changes were sequentially investigated at 2, 8 and 24 h after rapamycin or DMSO treatment, and compared against the phosphorylation status prior to treatment (0 h). In our phosphoproteome analysis, we identified 52 proteins whose phosphorylation statuses were changed after the rapamycin treatment. The 52 proteins and their ratios of phosphorylation changes after rapamycin or DMSO treatment are listed in Table S1 . Among them, the phosphorylation statuses increased for 8, 10 and 11 proteins, and decreased for 27, 31 . The values are averages of three independent experiments, error bars indicate standard deviation, and asterisks indicate a significant difference between two treatments (Student's t-test, P < 0.05). (b) Accumulation of starch with rapamycin treatment, nitrogen depletion, and rapamycin treatment in combination with nitrogen depletion conditions. The starch quantification in the rapamycin-treated cells was performed as described in (a). For the nitrogen depletion experiments, C. merolae SF12 cells were grown under normal growth conditions until OD 750 = 0.2-0.4, and then the cells were incubated in nitrogen-depleted medium. For the rapamycin treatment in combination with the nitrogen depletion condition, rapamycin was added to the C. merolae SF12 cells at the beginning of the incubation in nitrogen-depleted medium. The starch contents were measured 24 h after each treatment. ÀN and ND indicate nitrogen depletion and no significant difference, respectively. Other details are the same as those described in (a).
and 37 proteins at 2, 8 and 24 h after rapamycin treatment, respectively. The increased phosphorylation status in response to rapamycin may have been due to the activation of a different kinase following the inactivation of TOR. An increased phosphorylation status was observed for some proteins following the DMSO treatment, which is consistent with the results of a previous study (Nakatsumi et al., 2017) , and may have been due to cell growth over time. The phosphorylated residues detected by the phosphoproteomic analysis were all serine; except for one protein, CMH128C, which was phosphorylated at threonine residues. A single phosphorylated site was detected in 46 of the proteins, and multiple phosphorylation sites were detected in six of the proteins: CMO009C, CME172C, CMR346C, CMR185C, CML282C and CMR183C.
Gene ontology and motif analyses of target of rapamycin substrate proteins
To further characterize the TOR-dependent phosphorylated proteins identified by the phosphoproteome analysis, we performed a gene ontology (GO) analysis to categorize the proteins into various cellular functions. The GO analysis found that the TOR-dependent phosphorylated proteins are involved in various metabolic processes and were categorized in 12 different cellular function groups (Figure 2a ): 'carbohydrate metabolism' (13% of the identified proteins); 'protein binding' (11%); 'protein kinase and phosphatase' (11%); 'transcription' (10%); 'transport process' (4%); 'translation' (4%); 'RNA binding' (4%); 'amino acid metabolism' (2%); 'RNA degradation' (2%); 'phosphatidylinositol signaling' (2%); 'spliceosome' (2%); and 'other categorized proteins' (31%). This analysis indicates that the TOR-signaling pathway is involved in crucial cellular processes in C. merolae, as in yeast and animals (Huber et al., 2009; Hsu et al., 2011) . Previous studies identified a consensus phosphorylation motif in Saccharomyces cerevisiae TOR (Robitaille et al., 2013) , which is useful for characterizing the relationship between TOR and its substrates. To identify a consensus phosphorylation motif of TOR in C. merolae, the sequences of the peptides with a decreasing phosphorylation status identified by the phosphoproteomic analysis, including AE 5 amino acids on either side of the phosphorylation positions, were aligned and analyzed using the online tool kpLogo (Figure 2b ). The motif RXXSP, where X indicates any amino acid, was identified as a consensus phosphorylation motif of TOR in C. merolae.
Starch accumulation following the overexpression of the glycogenin-like protein CmGLG1 in the Cyanidioschyzon merolae SF12 strain
To evaluate the role of rapamycin-induced phosphorylation of protein(s) on starch accumulation in C. merolae cells, we analyzed two proteins: CMK020C (hereafter referred to as CmGLG1) and CMM317C (hereafter referred to as CmGS; Figure 3a ; Table S1 ). These proteins were denoted as being similar to glycogenin and a probable starch/glycogen synthase, respectively, in the C. merolae database (http://mero lae.biol.s.u-tokyo.ac.jp), because their homologs in eukaryotes play fundamental roles in starch/glycogen synthesis. Glycogenin functions in the initiation of starch/glycogen synthesis through self-glycosylation (Roach and Skurat, 1997) . In the reaction, the glucose molecule is transferred to glycogenin to produce an a-1-4-glycosidic linkage that results in a short primer sequence comprising about 10-20 glucose molecules (Pitcher et al., 1988) . Starch/glycogen synthase adds glucose to the growing chain of starch/ glycogen (Patron and Keeling, 2005) .
To characterize the roles of these two proteins in vivo, we overexpressed CmGLG1 and CmGS in the C. merolae SF12 strain. Because the phosphorylation of both proteins clearly decreased after the TOR-inactivation by rapamycin in comparison with the control (Figure 3a ; Table S1 ), we hypothesized that an overexpression would lead to a similar effect associated with the dephosphorylated form of each protein, namely starch accumulation. We constructed the plasmids for the overexpression of CmGLG1 and CmGS fused to a FLAG epitope tag under the control of the strong APCC promoter (Watanabe et al., 2011) , and obtained transformants using the plasmids and C. merolae SF12 strain. Quantitative real-time-polymerase chain reaction (qRT-PCR) analyses indicated that CmGS and CmGLG1 transcript levels were approximately 376-and 65-fold higher in the transgenic strains than in the control strain, respectively (Figure S1a). We also performed an immunoblot analysis with a monoclonal anti-FLAG antibody to confirm the CmGLG1 and CmGS expression in the transformants, and both proteins were successfully overexpressed in the SF12 strain (Figure S1b and c) . A starch quantification experiment showed that the starch content of the cells was increased by approximately 4.7-fold with CmGLG1 overexpression (CmGLG1ox) in comparison with the control strain. However, we did not find any significant changes with CmGS overexpression (CmGSox; Figure 3b ). Therefore, in the present study, we focused on characterizing the function of CmGLG1 in starch accumulation in C. merolae.
CmGLG1 is an authentic glycogenin in Cyanidioschyzon merolae
A domain search using a SMART algorithm (Letunic et al., 2011) predicted that CmGLG1 contains a glycosyltransferase domain (involved in the transfer of glucose), five transmembrane domains at the C-terminal, and a signal peptide at the N-terminal region ( Figure 3c ). Additionally, our phosphoproteome analysis revealed that the Ser613 residue at the C-terminal is dephosphorylated after a rapamycin treatment. Previous studies found that the C. merolae genome encodes four glycogenin-like proteins: CmGLG1, CMG174C, CMR358C (PDR1) (Yoshida et al., The phosphorylation sites and the five amino acids on either side were analyzed using the kpLOGO online tool. The sequence logos indicate the relative frequencies of the amino acid residues in proximity to the various phosphorylation sites. 2010) and CMJ262C (MDR1) (Yoshida et al., 2017) . Yoshida et al. (2010 Yoshida et al. ( , 2017 recently reported that PDR1 and MDR1 mediate the synthesis of polyglucan nanofilaments that assemble to form the plastid-and mitochondrion-division rings, respectively. To obtain experimental evidence that CmGLG1 functions as a glycogenin that is involved in starch accumulation, we performed a complementation test of CmGLG1 in the glg1glg2 double-knockout S. cerevisiae CC9 strain, which is unable to accumulate glycogen (Cheng et al., 1995) . Expression of CmGLG1 in S. cerevisiae CC9 complemented glycogen accumulation (Figure 3d ), which indicates that CmGLG1 is an authentic glycogenin and can initiate starch accumulation.
Dephosphorylation at serine 613 of CmGLG1 is crucial for starch accumulation
In the LC-MS/MS analysis, the serine 613 (Ser613) residue of CmGLG1 was identified as a potential phosphorylation site of TOR. The phosphorylation levels of the Ser613 residue decreased after rapamycin treatment and reached an almost 50% reduction 24 h after the incubation in comparison with time 0 (Figure 3a ; Table S1 ). In contrast, the phosphorylation levels under the DMSO treatment increased along with the incubation time. We also investigated the CmGLG1 phosphorylation changes using Phostag agarose, which captures phosphorylated amino acids
on peptides (Kinoshita-Kikuta et al., 2009). The phosphorylation level of CmGLG1 decreased significantly at 24 h after the rapamycin treatment (Figure 3e and f), suggesting our phosphoproteomic data were reliable and reproducible. We detected two bands corresponding to the exogenous FLAG-fused CmGLG1 in the phosphorylated and dephosphorylated fractions (Figure 3e ). Furthermore, we observed that the band pattern was unaffected by the k phosphatase treatment (Figure 3g ), indicating that the upper band was not the phosphorylated CmGLG1, but may be due to other modifications. This point will be discussed further in the Discussion.
To clarify the relationship between the phosphorylation of CmGLG1 by TOR-signaling and the accumulation of starch, we measured the starch content in CmGLG1ox under rapamycin treatment conditions. We expected that the enhanced starch content found with CmGLG1 overexpression would be further increased by rapamycin treatment if the CmGLG1 phosphorylation status involving Ser613 is essential for starch accumulation. It is noteworthy that the starch content in CmGLG1ox at time 0 was already significantly high in comparison with that of the control strain ( Figures 1a, 3b and 4a) . The starch content started to increase 24 h after rapamycin treatment in comparison with the DMSO condition, and was further increased by 48 h (Figure 4a ). Because these results suggested a relationship between the CmGLG1 phosphorylation status of Ser613 and starch accumulation, we next investigated the effects of phosphomimetic and phospho-null mutations to the residue on starch accumulation. (Figure 4b ). In this analysis, the starch contents were evaluated as relative levels (CmGLG1ox level set as 1.0) because we normalized the contents against exogenous CmGLG1 protein levels. These results support the hypothesis that dephosphorylation of the Ser613 residue of CmGLG1 plays a crucial role in starch accumulation in C. merolae. As indicated in Figure 4 (b), starch accumulation was not completely inhibited in the CmGLG1 S613D ox strain, suggesting that other mechanisms apart from the glycogenin/TOR-signaling pathway also contribute to the starch accumulation in C. merolae.
DISCUSSION
Starch is a major carbohydrate reserve in plants, and has important economic value due to its varying industrial applications in food and fuel production. In plants, the reaction catalyzed by ADP glucose pyrophosphorylase (AGPase) is a key step in starch accumulation. AGPase is regulated by redox modification, which occurs by inactivation of AGPase at an intermolecular disulfide bond between two subunits of the enzyme (Ballicora et al., 2000; Geigenberger et al., 2005; D ıaz-Troya et al., 2014) . However, other regulatory mechanisms that control starch synthesis have not been well characterized.
On the basis of our data presented herein, it seems likely that the checkpoint kinase TOR is involved in regulation of starch synthesis in C. merolae through the phosphorylation of the starch initiation protein CmGLG1 ( Figure 5 ). (b) Starch content in CmGLG1ox, CmGSox and the control strain. All three strains were grown until OD 750 was approximately 0.5. The starch contents were measured as described in Figure 1(a) . The values are averages of three independent experiments, error bars indicate standard deviation (SD), and an asterisk indicates a significant difference between Control and CmGLG1ox (Student's t-test, P < 0.05). CmGLG1ox and CmGSox indicate overexpression of CMK020C and CMM317C in the Cyanidioschyzon merolae SF12 strain, respectively. (c) Secondary structure of CmGLG1 protein as predicted using the SMART algorithm. The protein contains an N-terminal signal peptide, a C-terminal five transmembrane domain, Ser613 phosphorylated site identified by phosphoproteome analysis and a glycosyltransferase domain.
(d) Functional complementation of the Saccharomyces cerevisiae glycogenin mutant strain by CmGLG1. CmGLG1 was expressed in the glg1glg2 double-knockout S. cerevisiae CC9 strain. Wild-type yeast (EG3218-1A) and glg1glg2 expressing either the empty pGBTK vector or CmGLG1 were grown at 30°C for 2 days.
To examine the glycogen synthesis, cells were stained with 0.2% iodine and 0.4% potassium iodide, and spotted onto agar plates. The intensity of the color directly corresponds to the level of glycogen accumulated in the yeast strain. The yeast complementation assay was replicated using independent cell lines, and a representative image is shown.
(e) Phosphorylation pattern of CmGLG1 under rapamycin treatment conditions as determined by the Phos-tag agarose analysis. Specifically, 15 lg of protein prepared from the CmGLG1ox strain was loaded onto Phos-tag agarose. The dephosphorylated fraction (De-P) and phosphorylated fraction (P) were collected as described in the Experimental procedures section. Both fractions along with 15 lg total protein as an input (Inp) were analyzed by immunoblotting. Other details are as described in Figure 1 Target of rapamycin-inactivation by rapamycin leads to a 10-fold higher starch accumulation in comparison with the control (Figure 1a) . Furthermore, we also confirmed that TOR is a major regulator of starch accumulation in C. merolae, because no significant differences in starch contents were found between rapamycin treatment, nitrogen depletion, and nitrogen depletion in combination with rapamycin treatment (Figure 1b) . Similar to our observation, it has previously been found that conditional inactivation of TOR and reduced expression of LST8, a component protein of the TOR complex, in A. thaliana increases the intracellular starch content (Moreau et al., 2012; Caldana et al., 2013) . Recently, in the green alga Chlamydomonas reinhardtii, it was also observed that TOR-inactivation by rapamycin leads to significantly higher amounts of starch in comparison with control conditions (J€ uppner et al., 2018) . Although TOR-inactivation results in the accumulation of glycogen in yeast and mammalian cells, the regulation is conducted at the transcriptional level (Bentzinger et al., 2008; Franc ßois et al., 2012) . Therefore, starch/ glycogen accumulation following TOR-inactivation is a general response among eukaryotes, but the responsible mechanism may differ among organisms. Additionally, TOR is a conserved protein kinase affecting diverse cellular processes in eukaryotic cells (see Introduction). Furthermore, glycogenin-type proteins are also conserved among eukaryotes. To confirm the general regulation of starch accumulation via the TOR-mediated changes to the phosphorylation status of glycogenin proteins, we analyzed the amino acid sequence around the Ser613 residue of CmGLG1 and the corresponding protein in other eukaryotes. However, Ser613 and the RXXSP motif do not appear to be conserved among the homologous proteins in eukaryotes. In contrast, SP sites, which are recognized by proline-directed kinases, including TOR, were observed in almost all glycogenin-type proteins ( Figure S3 ). These findings imply that the regulation of starch accumulation through the phosphorylation of glycogenin is governed directly by TOR or via the TOR-signaling pathway in eukaryotes. (a) Induced starch accumulation by CmGLG1 overexpression and its content under target of rapamycin (TOR)-inactivation conditions. The starch content in the CmGLG1 overexpression strain (CmGLG1ox) under the indicated conditions was measured as described in Figure 1(a) . The values are averages of three independent experiments, error bars indicate standard deviation (SD), and an asterisk indicates a significant difference between two treatments (Student's t-test, P < 0.05). (b) Role of phosphorylation of CmGLG1 Ser613 in starch accumulation. CmGLG1ox, CmGLG1 S613A ox and CmGLG1 S613D ox strains were grown under normal conditions until OD 750 was approximately 1.0, and then the starch contents in each strain were measured as described in Figure 1(a) . Absolute starch content (pg cell À1 ) was normalized against signal intensities of exogenous CmGLG1 expression in each strain. The starch contents are presented as relative values (the value for CmGLG1ox is set to 1.0). The abundance of CmGLG1, CmGLG1 S613A and CmGLG1 S613D proteins analyzed by immunoblotting is presented as an inset. Other details are as described in Figure 1(a) . The values are averages of three independent experiments, error bars indicate standard deviation (SD), and asterisks indicate a significant difference between CmGLG1ox or CmGLG1 S613A ox and CmGLG1 S613D ox (Student's t-test, P < 0.05).
During the confirmation of exogenous CmGLG1 expression in the SF12 strain, we identified two distinct bands ( Figure S1b ), and we predicted that the upper band represented phosphorylated CmGLG1 ( Figure S1b ). However, we detected both bands in the dephosphorylated and phosphorylated fractions after the purification step using Phos-tag agarose (Figure 3e ). Furthermore, when we treated the protein extract with k phosphatase, we still detected the same band pattern, indicating that the upper band does not represent phosphorylated CmGLG1 (Figure 3g) . It is possible that the upper band represents the glycosylated form of CmGLG1, as the most studied regulation of glycogenin is self-glycosylation (Pitcher et al., 1988; Roach and Skurat, 1997) . This is likely the case, as the two bands were also detected in the CmGLG1 S613A ox and CmGLG1 S613D ox strains as well as in the control strain (Figure 4b) . The secondary structure analysis of CmGLG1 using the SMART online tool indicated that it contains a 20-amino acid signal peptide at the N-terminal region, and the intracellular localization is predicted to be within the 'secretory pathway' according to the TargetP algorithm (Nielsen et al., 1997; Emanuelsson et al., 2000) . The TargetP algorithm also predicted the presence of a cleavage site in CmGLG1 between amino acid residues 20 and 21. Our immunoblot analysis revealed two bands that differed by approximately 2-3 kDa in the cell extract of the CmGLG1ox strain ( Figure S1b ). Therefore, we propose the signal peptide is not associated with secretion and the upper band may be the immature form of CmGLG1. The mature form of the protein is transferred to the cytosol, the site of starch synthesis. There is also a possibility that CmGLG1 is localized in some membranes of organelle (s) or the cell membrane, and the domain needed for function as glycogenin faces to the cytosol as it has five transmembrane domains at C-terminal (Figure 3c ). Earlier investigations revealed that Tyr194 of glycogenin is important for initiating starch synthesis (Viskupic et al., 1992; Cao et al., 1993) . Our amino acid alignment analysis found that this Tyr residue is conserved in CmGLG1, but not in CmGLG2 ( Figure S2 ). These observations support our assumption that CmGLG1 is an authentic glycogenin with the ability to initiate starch synthesis in yeast (Figure 3d) . Only self-glycosylation of glycogenin is not involved in regulation of its catalytic activity, as Alonso et al. (1995) reported that mutation of Tyr194 of rabbit muscle glycogenin through substitution with phenylalanine or threonine still has the ability to initiate the glycogen synthesis. This suggests that apart from glycosylation, another mechanism mediates the catalytic activity of glycogenin. Cao et al. (1993) showed that the addition of 10 mM ATP decreases the activity of recombinant rabbit muscle glycogenin by almost 45%, while Lomako and Whelan (1988) identified a phosphoserine residue (Ser43) in the rabbit muscle glycogenin, which is phosphorylated following the addition of ATP or a protein kinase (Alonso et al., 1995) . These studies suggest that glycogenin is also regulated by its phosphorylation status; however, to date, there has been no information available about the kinase or phosphatase involved. Here, we have systematically shown that dephosphorylation of CmGLG1 by TOR-inactivation with rapamycin is a potential means of modulating glycogenin activity, and this process directs starch accumulation in the red alga C. merolae (Figures 1a and 3a) .
Because TOR is a protein kinase, it is obvious that TOR regulates cellular processes at the post-translational level via the modification of the phosphorylation statuses of its substrates. Protein phosphorylation is one of the most important post-translational modifications, and affects various aspects of target proteins, including activity, stability, interactions with other proteins and intracellular localization. To determine how TOR regulates various processes, in this study, we performed a comprehensive phosphoproteome analysis using powerful mass spectrometry and identified 52 proteins as candidate TOR substrates. The functions of the 52 identified proteins are diverse, suggesting that the TOR pathway regulates various cellular processes at the post-translational level (Figure 2a ; Table S1 ). A motif analysis of the identified phosphorylation sites using the online tool kpLogo revealed that RXXSP is a conserved motif (Figure 2b) . However, the frequency of the identified TOR recognition motif in the present study was less than that of previous studies on yeast and mammal phosphoproteomes (Hsu et al., 2011; Robitaille et al., 2013) . This lower frequency may have been because fewer TOR candidates were identified in this study. It is also possible that the TOR substrate recognition motif is not as highly conserved in the primitive red alga C. merolae as it is in yeast and mammals. The particular recognition sequence of amino acids near the phosphorylation site is also useful for targeting substrates. A phosphorylated serine residue with an adjacent proline residue at +1 is a characteristic substrate recognition motif in serine/threonine kinases, including TOR (Amanchy et al., 2011; Hsu et al., 2011; Robitaille et al., 2013) . We also identified proline at the +1 position in our motif analysis (Figure 2b ). Furthermore, we identified an arginine residue at the À3 position, which is also present in consensus motifs that are phosphorylated by yeast and mammalian TOR kinases (Hsu et al., 2011; Robitaille et al., 2013) . These results suggest that the TOR substrate recognition motifs in plant lineages are similar to those in other eukaryotes.
In our phosphoproteome analysis, we identified Mda1 (Table S1 ), which was previously reported to be phosphorylated in the M phase and involved in mitochondrial division (Nishida et al., 2007) . We also detected another protein, E2F (Table S1) , as a candidate TOR substrate. The phosphorylated form of this protein promotes the G1/S transition (Miyagishima et al., 2014) . The above two examples suggest that TOR is involved in cell cycle regulation, and also that the phosphoproteome data obtained in the present study seem to be reliable. Because TOR-inactivation by rapamycin also inhibits cell growth, it is possible that the changes in the phosphorylation of various proteins might be due to the combined effects of rapamycininduced TOR-inactivation and growth inhibition. Apart from proteins with known cellular functions, almost 33% of the proteins we identified in our phosphoproteome analysis had no known function. Regulation of post-translational modifications by phosphorylation is poorly understood, not only in C. merolae, but also in other photosynthetic eukaryotes. Therefore, further studies are required to reveal the TOR-dependent roles of these proteins in cellular processes.
The accelerated starch accumulation observed with CmGLG1 overexpression clearly indicates that glycogenin is a key enzyme that is involved in starch initiation in C. merolae. The regulatory mechanism of CmGLG1 activity involves dephosphorylation of the Ser613 residue, the phosphorylation of which is regulated by the TOR-signaling pathway ( Figure 5 ). As shown in Figure 5 , under normal growth conditions, TOR and its signaling pathway are active and CmGLG1 is phosphorylated. Under favorable growth conditions, cells will accumulate less starch. In contrast, a rapamycin treatment or nitrogen depletion inactivates TOR, and the TOR-signaling pathway induces a dephosphorylation of CmGLG1, leading to an increase in the accumulation of starch in C. merolae cells. Further studies using other algae like Chlamydomonas species, as well as higher plants, such as A. thaliana, will provide more detailed information about the conserved fundamental molecular mechanism of starch accumulation in plant lineages. This information will help to develop technologies to improve starch biosynthesis productivity, and concomitantly improve sustainable biomass and bioenergy production.
EXPERIMENTAL PROCEDURES Strain and growth conditions
The Cyanidioschyzon merolae SF12 strain was grown in MA2 medium (Imamura et al., 2010) supplemented with air containing 2% CO 2 at 40°C under continuous white light (50 lmol m À2 sec À1 ), as described previously by Imamura et al. (2017) . For the TOR-inactivation by rapamycin treatment, C. merolae SF12 cells in the logarithmic growth phase (OD 750 = 0.2-0.4) were treated with rapamycin at a final concentration of 2 lM. For the control experiments, an equal volume of DMSO was added to the culture because the rapamycin was dissolved in DMSO. The nitrogen depletion experiments were carried out as described previously (Imamura et al., 2009) . For the TOR-inactivation and nitrogen depletion experiments, cells were incubated in the nitrogen-depleted medium with rapamycin at a final concentration of 2 lM.
Quantification of starch in Cyanidioschyzon merolae cells
One milliliter of C. merolae cells was harvested by centrifugation at 12 000 g for 10 min and stored at À20°C until used. The starch content in the C. merolae cells was essentially estimated as described previously (Takusagawa et al., 2016) . Briefly, 100 ll of 10% (w/v) sodium dodecyl sulfate (SDS) was added to the cell pellet and incubated for 15 min at room temperature (RT). After centrifugation at 12 000 g for 10 min, the resulting pellet was washed with 80% (v/v) ethanol warmed to 50°C, and then vortexed for 5 min. The whole solution was centrifuged at 12 000 g for 10 min, and the resultant pellet was dissolved in 75 ll milliQ water and boiled at 98°C for 15 min. After cooling at RT, 125 ll of 60% perchloric acid (Wako, http://ffwk.fujifilm.co.jp/en/index. html) was added to the solution and vortexed for 15 min. Finally, 300 ll milliQ water was added to the solution, mixed well and centrifuged at 12 000 g for 10 min. The sugar content (pg ml À1 ) in 200 ll supernatant was determined using the phenol-sulfuric acid method, as described below. An equal volume of 5% (w/v) phenol solution was added to 200 ll supernatant and then 1 ml concentrated sulfuric acid. After incubating for 10 min at RT, the sample was further incubated for 20 min at 40°C and the absorbance was recorded at 490 nm (Dubois et al., 1956) . A standard curve was prepared using 20-200 lg/200 ll glucose solutions. The sugar content was converted to pg cell À1 using the total cell count per milliliter. For the cell count, the culture used for each time point was suitably diluted with MA2 medium, and the cell number was measured using a disposable hematocytometer. To calculate relative starch levels in each strain, the absolute starch content (pg cell exogenous CmGLG1 expression, which were detected by an immunoblot analysis. The exogenous CmGLG1 expression levels were measured using ImageJ software (http://rsb.info.nih.gov/ij).
Phosphoproteome analysis
Cyanidioschyzon merolae SF12 cells in the logarithmic growth phase (OD 750 = 0.2-0.4) were treated with rapamycin (final concentration of 2 lM) or DMSO for 0, 2, 8 and 24 h, and then harvested by centrifugation, frozen immediately in liquid nitrogen, and stored at À80°C until used. The frozen cells were thawed on ice, resuspended in a urea solution (7 M urea, 2 M thiourea), and disrupted by sonication (Branson Sonifier 250; output level 1.0, duty 50, 10 sec, three times, Fisher scientific, https://www.fishe rsci.com). The extracted protein was then used for a phosphoproteome analysis: 100 lg protein was dissolved in 20 ll urea solution. An iTRAQ Labeling Kit (Applied Biosystems, https:// www.thermofisher.com) was used for trypsin digestion and peptide labeling. The labeled peptides were purified on a cation exchange spin column (Vivapure S Mini H, Sartorius, https:// www.sartorius.com), eluted with 150 mM or 1 M KCl and 10 mM potassium phosphate in 20% (v/v) acetonitrile at pH 3.0 (CationExchange system Buffers, Applied Biosystems), and then each fraction was desalted (Sep-Pak C18 Plus Light Cartridge, Waters, http://www.waters.com). Phosphopeptides were enriched using a Titansphere Phos-TiO kit (GL Sciences, https://www.glsciences.c om). After an evaporation to remove the acetonitrile, aliquots were loaded onto a C18 tip column (Rappsilber et al., 2007) and stored at À80°C until used. Mass spectrometry was performed using an LTQ Orbitrap Velos with ETD mass spectrometer (Thermo Fisher Scientific) equipped with a PAL HTC-xt autosampler (AMR, Pal system, https://www.palsystem.com) and an Advance nano UHPLC system (Michrom BioResources, https:// www.crunchbase.com). The peptides were separated on a PepSwift monolithic column (100 lm internal diameter 9 25 cm; Thermo Fisher Scientific) at a 300 nl min À1 flow rate with a linear gradient generated by aqueous solvent A (0.1% formic acid in water) and organic solvent B (100% acetonitrile): 1% B to 20% B in 230 min, to 27.5% B in 230 min, to 35% B in 235 min, to 95% B in 236.5 min, to 95% B for 1.5 min, and finally to 0% B in 240 min. MS1 scans from m/z = 375-1500 were performed in the mass spectrometer with the resolution set to 60 000 with a lockmass at m/z = 445.120025. This was followed by sequential isolation of the 10 most intense precursor ions and acquisition of MS2 by higher energy collisional dissociation with the resolution set to 7500. The settings for the MS2 scans were as follows: minimal signal intensity required = 1000, isolation width = 1.2 m/z, AGC target = 50 000, maximum ion injection time = 400 msec, normalized collision energy = 40-50% with two steps, activation time = 0.1 msec, and dynamic exclusion enabled with a 90-sec exclusion duration. The MS/MS data were acquired over 250 min after the LC gradient was commenced. Proteome Discoverer version 1.4 software (Thermo Fisher Scientific), a MAS-COT version 2.4.1 search engine (Matrix Science, http://www.ma trixscience.com/) and the C. merolae protein database (http://me rolae.biol.s.u-tokyo.ac.jp/download/orf.fasta) were used for protein identification and quantification. A maximum of four trypsin miscleavages were allowed. The peptide mass tolerance and MS1/MS2 tolerance were set at 5 ppm and 0.02 Da, respectively. Protein N-terminal acetylation (+42.0106), oxidation of methionine (+15.9949), phosphorylation at serine/threonine (+79.9663) and iTRAQ 8-plex at peptide N-ter and lysine were considered as variable modifications. After the LC-MS/MS analysis, reporter ion intensities of each peptide were determined, and the foldchange values were automatically calculated by the Proteome Discoverer (version 1.4) program (Thermo Fisher Scientific). The fold-change value for the 0 h time point was set as 1, and the phosphorylation changes at 2, 8 and 24 h were calculated (Table S1 ).
Phosphoproteome data analysis
Phosphoproteins with increased or decreased phosphorylation levels after a rapamycin treatment were identified based on the following criteria: ≥ 1.2-fold increase for phosphoproteins with an increased phosphorylation status; ≤ 0.85-fold decrease for phosphoproteins with a decreased phosphorylation status after 2, 8 and 24 h of a rapamycin treatment compared with the phosphorylation level at the 0 h time point. For functional classifications, rapamycin-induced phosphoproteins were categorized into the respective molecular functions using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database (Kanehisa and Goto, 2000) . To analyze the phosphorylated residue and the five amino acids on either side, the kpLogo online tool was used, with default settings (Wu and Bartel, 2017) . This is a probability-based online tool that generates logos with each amino acid presented vertically and scaled to its log 10 value. After generating the logo, a consensus amino acid was identified if an amino acid had a 22% probability of occurring at a particular position in all analyzed sequences.
Immunoblot analysis
Immunoblot analysis was performed as described previously (Imamura et al., 2003 (Imamura et al., , 2008 , with slight modifications. Briefly, the total protein was isolated from each transformant using the following method. Approximately 20 ml of growing cells (OD 750 = 0.5-0.8) was centrifuged at 1200 g for 10 min, and the resulting pellet was dissolved in 250 ll of extraction buffer containing 25 mM Tris-HCl pH 8.0, OComplete Mini EDTA-free protease inhibitor mixture (Roche Applied Science, https://lifescience.roche.com) and phosphatase inhibitor cocktail (Nacalai Tesque, https://www.nacalai.co.jp/global/). The cells were disrupted by vortexing at 4°C (scale 8, 5 min, TurboMix attached to Vortex Genie 2; Scientific Industries, https://www.sc ientificindustries.com) with 100 mg glass beads (≤ 106 lm; Sigma, https://www.sigmaaldrich.com). After cells were disrupted, the tube was centrifuged at 12 000 g for 15 min and the supernatant (total protein solution) was used for an immunoblot analysis. The protein solution was mixed with an equal volume of 2 9 sample buffer (Laemmli, 1970) and incubated at 37°C for 30 min before SDS-polyacrylamide gel electrophoresis (PAGE). FLAG-fused protein was detected using antibodies against FLAG-tag (Sigma).
Phos-tag agarose and immunoblot analyses
A Phos-tag agarose analysis was performed as previously described (Kinoshita-Kikuta et al., 2009) . First, we prepared a spincentrifuge unit using a 0.5-ml tube. A small pore was made at the bottom of the tube with a 21-G needle (TERUMO, http://www.te rumo-europe.com). Next, 40 ll Phos-tag agarose (Wako) was added to the prepared spin-centrifuge unit, which was centrifuged at 2000 g for 20 sec to remove the storage buffer. We then added 40 ll balancing buffer [0.1 M Tris-CH 3 COOH pH 7.5, 1.0 M CH 3 COONa and 10 lM Zn(OCOCH 3 ) 2 ] to the agarose beads, which were subsequently incubated for 5 min at room temperature. The spin-centrifuge unit was centrifuged at 2000 g for 20 sec and the filtrate was discarded. The agarose beads were washed three times using 40 ll binding/washing solution (0.1 M Tris-CH 3 COOH pH 7.5 and 1.0 M CH 3 COONa). Total protein (15 lg) was applied to the washed agarose beads, which were then incubated for 5 min at room temperature. The unit was centrifuged at 2000 g for 20 sec, and the flowthrough fraction was collected (dephosphorylated protein fraction). The agarose beads were washed once using 100 lL binding/washing solution. Distilled water (40 ll or more) was applied to collect agarose beads to a new centrifuge tube. The agarose beads were transferred to a new centrifuge tube after dissolving in distilled water (≥ 40 ll). The tube was centrifuged at 2000 g for 20 sec and the agarose beads were collected (phosphorylated protein fraction). The total protein, flowthrough fraction (dephosphorylated protein fraction) and collected agarose beads (phosphorylated protein fraction) were mixed with an equal volume of 2 9 sample buffer (Laemmli, 1970) and incubated at 37°C for 30 min. The FLAG-fused protein was detected by an immunoblot analysis using antibodies against FLAG-tag (Sigma).
Construction of CmGS, CmGLG1ox, CmGLG1
S613A ox and CmGLG1 S613D ox strains
The CmGLG1 (CMK020C) gene was amplified using the F1 (5 0 -TTCTTCGTTCGTTGACCCCCATGAGGCTCAAGTTTTTTGC-3 0 ) and R1 (5 0 -TGCAGGTCGACTCTAGACCCCGGACTGCGCAACTGGTGCC-3 0 ) primers, and C. merolae genomic DNA as a template. pSUGA was used as an expression vector because it contains a strong APCC promoter and a FLAG epitope tag coding sequence (Fujii et al., 2013) . The amplified fragment was cloned into SmaI-digested pSUGA using a SLiCE method (Zhang et al., 2012) to construct the pGLG1ox vector for producing CmGLG1 with a C-terminal FLAG epitope tag in C. merolae. For construction of the pGLG1 S613A ox and pGLG1 S613D ox plasmids, inverse-polymerase chain reaction (PCR) was conducted using primer sets F3 (5 0 -GACCGATGAGCC CACGCATACGCCTCGTC-3 0 ) and R3 (5 0 -GTGGGCTCATCGGTCAG TAGTACGGCCGT-3 0 ), and F4 (5 0 -GACCGATGCGCCCACGCATACGC CTCGTC-3 0 ) and R4 (5 0 -GTGGGCGCATCGGTCAGTAGTACGGCC GT-3 0 ), respectively, with pGLG1ox as a template. The resultant pGLG1ox, pGLG1 S613A ox and pGLG1 S613D ox plasmids were transformed into the SF12 host strain as described previously . After 2-3 weeks of incubation, emergent colonies were subcultured and genomic DNA was isolated from each transformant. The DNA was used as a template for a PCR analysis to confirm positive transformants using the primer set F2 (5 0 -ATGAGGCTCAAGTTTTTTGC-3 0 ) and R2 (5 0 -TCACTTGTCA TCGTCATCCTTGTAATCGAT-3 0 ). The CmGS (CMM317C) gene was amplified using primers GSF (5 0 -TTCTTCGTTCGTTGACCCCCA TGCCAGGCAGCACACAGCG-3 0 ) and GSR (5 0 -TGCAGGTCGACTC TAGACCCTGGGGTCTGTCGAGGCACCT-3 0 ), and C. merolae genomic DNA as a template. The amplified fragment was cloned into SmaI-digested pSUGA, as described above, to construct the pGSox vector for producing CmGS with a C-terminal FLAG epitope tag in C. merolae. Expression of FLAG-fused CmGS, CmGLG1, CmGLG1 S613A and CmGLG1 S613D proteins was examined by immunoblot analysis. The PCR and immunoblot analyses confirmed the identities of the CmGSox, CmGLG1ox, CmGLG1 S613A ox and CmGLG1 S613D ox strains, as well as the FLAG-fused CmGS, CmGLG1, CmGLG1 S613A and CmGLG1 S613D strains. A control strain was also obtained by transforming SF12 with the empty vector pSUGA.
Complementation of CmGLG1 in yeast
Saccharomyces cerevisiae strains CC9 (glg1glg2 double knockout) and EG328-1A (wild-type) were kindly provided by Prof. Wayne Wilson (Des Moines University, USA, https://www.dmu.edu). For construction of the pGBTKCmGLG1 plasmid, part of the pGBTK plasmid (Yoshimura et al., 2004) without the GB4 sequence was amplified using an inverse PCR method with the primer set F5 (5 0 -CCGGAATTCCCGGGGATCCGTCGACCTGCAGCCAA-3 0 ) and R5 (5 0 -CTTTCAGGAGGCTTGCTTCAAGCTTGGAGTTGATT-3 0 ), while the CmGLG1 fragment was amplified using the primers F6 (5 0 -CAAGCC TCCTGAAAGATGAGGCTCAAGTTTTTTGCACTC-3 0 ) and R6 (5 0 -CCC CGGGAATTCCGGCTACGGACTGCGCAACTGG-3 0 ), with C. merolae genomic DNA as a template. The two amplified fragments were joined using a SLiCE method (Zhang et al., 2012) to construct pGBTKCmGLG1. The pGBTKCmGLG1 plasmid was transformed into S. cerevisiae strain CC9 using a Frozen-EZ Yeast Transformation II kit (Invitrogen). The S. cerevisiae CC9 cells containing pGBTK were used as a negative control. Transformants were selected by tryptophan prototrophy on a yeast synthetic minimaldefined (SD) medium lacking tryptophan. Glycogen accumulation was examined as described by Garc ıa et al. (2017) . Specifically, 10 ml of exponentially growing yeast strains was harvested by centrifugation at 10 500 g for 2 min. Cell pellets were resuspended in 1 ml of 0.2% (w/v) iodine and 0.4% (w/v) potassium iodide. After incubating for 3 min at room temperature, the whole suspension was centrifuged at 10 500 g for 3 min. The resulting pellets were resuspended in 30 ll of the same solution and spotted on agar plates, which were immediately photographed.
Phosphatase treatment
For the k phosphatase treatment, the CmGLG1ox strain was grown until it reached the logarithmic growth phase, and then total protein was extracted as described in the previous section. A 15-lg aliquot of total protein was treated with 40 U k phosphatase (NEB, https://www.neb.com), with or without the addition of a 25-fold dilution of phosphatase inhibitor cocktail (Nacalai Tesque), and then incubated for 60 min at 30°C. Proteins were separated by 10% SDS-PAGE and analyzed by immunoblotting with a monoclonal anti-FLAG antibody (Sigma).
RNA preparation and quantitative real-time-polymerase chain reaction
The extraction of total RNA and the quantitative real-time (qRT)-PCR assay were completed as previously described (Imamura et al., 2018) . Specifically, 10-15 ml of C. merolae cultures was centrifuged, and the resulting pellets were dissolved in 500 ll RNA extraction buffer [50 mM Tris-HCl pH 6.8, 5 mM EDTA and 0.5% (w/ v) SDS]. Next, 500 ll of acidic phenol was added, after which the solution was incubated at 65°C for 8 min with intermittent mixing. The tube was then centrifuged. The supernatant was transferred to a new tube, after which an equal amount of phenol:chloroform: isoamyl alcohol (25:24:1) was added. The tubes were mixed vigorously and centrifuged. The supernatant was transferred to a new tube and subjected to an ethanol precipitation. The isolated RNA was treated with 0.1 U ll À1 DNase I (Takara, http://www.takarabio.com/index.html) and 0.4 lg ll À1 proteinase K (Invitrogen). The extracted RNA was subsequently treated with phenol:chloroform: isoamyl alcohol (25:24:1) and precipitated with ethanol. The resulting purified RNA (0.1-0.5 µg) was used as a template for synthesizing cDNA fragments with the ReverTra Ace â qPCR RT Master Mix with gDNA Remover Kit (Toyobo, http://www.toyobo-global.c om/seihin/xr/lifescience/). The cDNA was used as a template for a qRT-PCR assay with the following primers: CmGLG1_QRT-F (5 0 -CTGGAAGTGGGTTGCTTTGC-3 0 ) and CmGLG1_QRT-R (5 0 -ATT-CCCCAGCCAGAGAAACG-3 0 ) for CmGLG1; CmGS_QRT-F (5 0 -CAG-CAAGTGCCAGATCCTCA-3 0 ) and CmGS_QRT-R (5 0 -AAATACCC CCGGTAGCGTTG-3 0 ) for CmGS.
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